Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 May;39(5):1206–1208. doi: 10.1128/aac.39.5.1206

Results of German multicenter study of antimicrobial susceptibilities of Trichophyton rubrum and Trichophyton mentagrophytes strains causing tinea unguium. German Collaborative Dermatophyte Drug Susceptibility Study Group.

H C Korting 1, M Ollert 1, D Abeck 1
PMCID: PMC162715  PMID: 7625820

Abstract

Thirty-two strains of Trichophyton rubrum and 16 strains of Trichophyton mentagrophytes isolated from patients with tinea unguium in various parts of Germany were subjected to a microdilution test with six systemic or topical antimycotic agents. Apart from griseofulvin, there were no species-specific differences between the two species. Terbinafine was the most active antimycotic agent, with a MIC not exceeding 0.05 micrograms/ml.

Full Text

The Full Text of this article is available as a PDF (179.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Artis W. M., Odle B. M., Jones H. E. Griseofulvin-resistant dermatophytosis correlates with in vitro resistance. Arch Dermatol. 1981 Jan;117(1):16–19. [PubMed] [Google Scholar]
  2. Georgii A., Korting H. C. Antifungal susceptibility testing with dermatophytes. Mycoses. 1991 May-Jun;34(5-6):193–199. doi: 10.1111/j.1439-0507.1991.tb00643.x. [DOI] [PubMed] [Google Scholar]
  3. Georgii A., Korting H. C. Antifungal susceptibility testing with dermatophytes. Mycoses. 1991 May-Jun;34(5-6):193–199. doi: 10.1111/j.1439-0507.1991.tb00643.x. [DOI] [PubMed] [Google Scholar]
  4. Granade T. C., Artis W. M. Antimycotic susceptibility testing of dermatophytes in microcultures with a standardized fragmented mycelial inoculum. Antimicrob Agents Chemother. 1980 Apr;17(4):725–729. doi: 10.1128/aac.17.4.725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Grant S. M., Clissold S. P. Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Drugs. 1989 Mar;37(3):310–344. doi: 10.2165/00003495-198937030-00003. [DOI] [PubMed] [Google Scholar]
  6. Koopman R. J., van Merriënboer F. C., Vreden S. G., Dolmans W. M. Molluscum contagiosum; a marker for advanced HIV infection. Br J Dermatol. 1992 May;126(5):528–529. doi: 10.1111/j.1365-2133.1992.tb11835.x. [DOI] [PubMed] [Google Scholar]
  7. Korting H. C., Rosenkranz S. In vitro susceptibility of dermatophytes from Munich to griseofulvin, miconazole and ketoconazole. Mycoses. 1990 Mar;33(3):136–139. doi: 10.1111/myc.1990.33.3.136. [DOI] [PubMed] [Google Scholar]
  8. Korting H. C., Schäfer-Korting M. Is tinea unguium still widely incurable? A review three decades after the introduction of griseofulvin. Arch Dermatol. 1992 Feb;128(2):243–248. [PubMed] [Google Scholar]
  9. Korting H. C., Schäfer-Korting M., Zienicke H., Georgii A., Ollert M. W. Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole. Antimicrob Agents Chemother. 1993 Oct;37(10):2064–2068. doi: 10.1128/aac.37.10.2064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Meinhof W. Isolierung und Identifizierung von Dermatophyten. Zentralbl Bakteriol. 1990 Jun;273(2):229–245. [PubMed] [Google Scholar]
  11. Merk H. F. Antimykotika. Teil II. Hautarzt. 1993 Apr;44(4):257–267. [PubMed] [Google Scholar]
  12. Odds F. C., Milne L. J., Gentles J. C., Ball E. H. The activity in vitro and in vivo of a new imidazole antifungal, ketoconazole. J Antimicrob Chemother. 1980 Jan;6(1):97–104. doi: 10.1093/jac/6.1.97. [DOI] [PubMed] [Google Scholar]
  13. Petranyi G., Meingassner J. G., Mieth H. Antifungal activity of the allylamine derivative terbinafine in vitro. Antimicrob Agents Chemother. 1987 Sep;31(9):1365–1368. doi: 10.1128/aac.31.9.1365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Polak A. Virulence of Candida albicans mutants. Mycoses. 1992 Jan-Feb;35(1-2):9–16. doi: 10.1111/j.1439-0507.1992.tb00813.x. [DOI] [PubMed] [Google Scholar]
  15. Roseeuw D., De Doncker P. New approaches to the treatment of onychomycosis. J Am Acad Dermatol. 1993 Jul;29(1):S45–S50. doi: 10.1016/s0190-9622(08)81837-3. [DOI] [PubMed] [Google Scholar]
  16. Schäfer-Korting M., Korting H. C., Dorn M., Mutschler E. Ketoconazole concentrations in human skin blister fluid and plasma. Int J Clin Pharmacol Ther Toxicol. 1984 Jul;22(7):371–374. [PubMed] [Google Scholar]
  17. Schäfer-Korting M. Pharmacokinetic optimisation of oral antifungal therapy. Clin Pharmacokinet. 1993 Oct;25(4):329–341. doi: 10.2165/00003088-199325040-00006. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES